Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Eurofins Discovery Announces Formation of its New Scientific Advisory Board 2022-05-24 23:00
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment 2022-05-24 21:00
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention 2022-05-24 20:00
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis 2022-05-24 19:00
New Study Shows Critical Role of 1,5-Anhydroglucitol (1,5-AG) in COVID-19 Pathogenesis by Binding to the COVID-19 Spike Protein 2022-05-24 19:00
DERMALOG and Rheinmetall join forces for increased vehicle security 2022-05-24 16:00
Nanoform 1Q 2022 report: Quarterly record of new projects and new customers 2022-05-24 14:16
Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma 2022-05-24 14:15
SwipeRx secures US$27 Million in Series B Funding to accelerate growth across Southeast Asia 2022-05-24 10:00
OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time 2022-05-24 09:00
SCAI & CBS Pulmonary Hypertension Masterclass 2022: Based on Global Perspectives Focusing on New Breakthroughs 2022-05-24 08:30
HistoSonics Announces Agreement with GE Healthcare 2022-05-23 21:00
New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer 2022-05-23 20:46
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand 2022-05-23 20:28
Antengene Announces First Patient Dosed in the Phase I/II SWATCH Study of XPOVIO® (Selinexor) for the Treatment of B-Cell Non-Hodgkin Lymphomas 2022-05-23 10:10
Tulip Partners with Stanley Black & Decker on Global Operations Platform 2022-05-21 03:53
Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma 2022-05-21 01:19
Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias 2022-05-20 20:08
Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology 2022-05-20 16:17
Lipidor updates on Phase III study of AKP02 in treatment of psoriasis - half of patients now recruited 2022-05-20 14:56
1 150 151 152 153 154 493